Media Centre
Helping you get on with life
ProStrakan announces exclusive licence and collaboration agreement with Amgen to develop and commercialise compounds for renal disease
News Service
To receive mailings when this news page is updated, please enter your email address below and click submit. Thank you.
13/7/2006

Click here for full press release

Back to listing